
Chrysos posts $88.1M revenue and $27.2M EBITDA in FY26
- Chrysos Corporation (ASX:C79) reported a total revenue of $88.1 million for fiscal year 2026, alongside an EBITDA of $27.2 million.
- Following the announcement, the Chrysos Corporation share price was up at $7.05.
- The company attributed the financial performance to increasing global deployments and high utilisation of its technology.
Chrysos Corporation (ASX:C79) announced total revenue of $88.1 million and an EBITDA of $27.2 million for the fiscal year 2026.
The latest figures compare against a total revenue of $66.1 million and an EBITDA of $16.1 million reported in the previous financial year.
"More mines and labs are choosing PhotonAssay for safer, faster, more accurate analysis", said Chrysos Managing Director and CEO Dirk Treasure.
The business signed 24 new lease agreements during the period and recorded total sample volumes of 11.3 million.
The firm finished the period with $25.9 million in cash and $140 million in undrawn debt.
Following the announcement, the Chrysos Corporation share price was up at $7.05.
The Adelaide-based technology provider specialises in automated assay processes for the global mining and resources sector.
